CALM3

Protein-coding gene in the species Homo sapiens
CALM3
Available structures
PDBHuman UniProt search: PDBe RCSB
List of PDB id codes

2VAY, 1Y6W, 4JPZ, 3UCY, 1WRZ, 4G28, 1ZOT, 1YRT, 1IQ5, 1CDL, 2LL6, 3HR4, 4BW7, 4BW8, 1YR5, 4J9Y, 4LZX, 1L7Z, 1ZUZ, 2BE6, 2V01, 1XFV, 2M55, 1CTR, 2I08, 2MG5, 2R28, 3O77, 4UPU, 2L7L, 2K0F, 2M0K, 4V0C, 1SW8, 2WEL, 3DVK, 2M0J, 3DVM, 2KUH, 1K90, 1K93, 4G27, 1CLL, 2KUG, 1XFX, 4DJC, 2LQC, 2LQP, 4L79, 2W73, 2LV6, 1NKF, 2JZI, 3UCT, 4GOW, 1J7O, 1PK0, 4Q5U, 2V02, 3BYA, 4Q57, 2KNE, 1YRU, 2Y4V, 2L53, 2F3Y, 3O78, 1LVC, 4M1L, 2K0E, 1S26, 4DCK, 1XFW, 3SUI, 2X0G, 3EWV, 1XFY, 2LL7, 4OVN, 3J41, 2BKI, 1SK6, 3DVJ, 3UCW, 2LGF, 4UMO, 3DVE, 4JQ0, 3OXQ, 2K61, 1XFU, 3SJQ, 2K0J, 4BYF, 1J7P, 3G43, 3EWT, 4J9Z, 1XFZ, 2F3Z, 1IWQ, 2N6A, 2HF5, 2N27, 4ZLK, 5COC,%%s2HF5

Identifiers
AliasesCALM3, HEL-S-72, PHKD, PHKD3, calmodulin 3 (phosphorylase kinase, delta), CaM, CaMIII, calmodulin 3, CAM1, CAMB, CALM, CAM2, CPVT6, LQT16
External IDsOMIM: 114183; HomoloGene: 134804; GeneCards: CALM3; OMA:CALM3 - orthologs
Gene location (Human)
Chromosome 19 (human)
Chr.Chromosome 19 (human)[1]
Chromosome 19 (human)
Genomic location for CALM3
Genomic location for CALM3
Band19q13.32Start46,601,074 bp[1]
End46,610,782 bp[1]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • prefrontal cortex

  • right frontal lobe

  • left testis

  • right testis

  • right hemisphere of cerebellum

  • nucleus accumbens

  • amygdala

  • cingulate gyrus

  • anterior cingulate cortex

  • Brodmann area 9
    n/a
More reference expression data
BioGPS
n/a
Gene ontology
Molecular function
  • calcium ion binding
  • protein binding
  • calcium channel inhibitor activity
  • protein kinase binding
  • titin binding
  • protein serine/threonine kinase activator activity
  • transmembrane transporter binding
  • metal ion binding
  • protein phosphatase activator activity
  • adenylate cyclase binding
  • disordered domain specific binding
  • inositol-1,4,5-trisphosphate 3-kinase activity
  • ligand-gated ion channel activity
  • adenylate cyclase activator activity
  • protein domain specific binding
  • nitric-oxide synthase regulator activity
  • type 3 metabotropic glutamate receptor binding
  • N-terminal myristoylation domain binding
  • phosphatidylinositol 3-kinase binding
  • protein N-terminus binding
  • calcium-dependent protein binding
  • nitric-oxide synthase binding
  • kinase activity
Cellular component
  • cytoplasm
  • cytosol
  • calcium channel complex
  • extracellular region
  • spindle microtubule
  • neuron projection
  • cytoskeleton
  • nucleus
  • centrosome
  • voltage-gated potassium channel complex
  • extracellular exosome
  • spindle pole
  • growth cone
  • plasma membrane
  • spindle
  • sarcomere
  • nucleoplasm
  • vesicle
  • postsynaptic density
  • catalytic complex
  • microtubule organizing center
  • synaptic vesicle membrane
  • mitochondrial membranes
  • protein-containing complex
  • myelin sheath
  • intracellular anatomical structure
Biological process
  • muscle contraction
  • response to amphetamine
  • positive regulation of protein serine/threonine kinase activity
  • detection of calcium ion
  • Fc-epsilon receptor signaling pathway
  • positive regulation of phosphoprotein phosphatase activity
  • G2/M transition of mitotic cell cycle
  • regulation of high voltage-gated calcium channel activity
  • positive regulation of DNA binding
  • substantia nigra development
  • positive regulation of protein dephosphorylation
  • inositol phosphate metabolic process
  • positive regulation of nitric-oxide synthase activity
  • glycogen catabolic process
  • positive regulation of cyclic-nucleotide phosphodiesterase activity
  • G protein-coupled receptor signaling pathway
  • regulation of cytokinesis
  • regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion
  • regulation of rhodopsin mediated signaling pathway
  • response to corticosterone
  • negative regulation of peptidyl-threonine phosphorylation
  • activation of adenylate cyclase activity
  • regulation of heart rate
  • positive regulation of ryanodine-sensitive calcium-release channel activity
  • response to calcium ion
  • regulation of ryanodine-sensitive calcium-release channel activity
  • regulation of nitric-oxide synthase activity
  • platelet degranulation
  • negative regulation of ryanodine-sensitive calcium-release channel activity
  • MAPK cascade
  • positive regulation of peptidyl-threonine phosphorylation
  • positive regulation of protein autophosphorylation
  • regulation of cardiac muscle contraction
  • regulation of cell communication by electrical coupling involved in cardiac conduction
  • regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
  • calcium-mediated signaling
  • ion transmembrane transport
  • Wnt signaling pathway, calcium modulating pathway
  • positive regulation of GTPase activity
  • protein methylation
  • establishment of protein localization to membrane
  • establishment of protein localization to mitochondrial membrane
  • regulation of synaptic vesicle endocytosis
  • regulation of synaptic vesicle exocytosis
  • phosphorylation
Sources:Amigo / QuickGO
Orthologs
SpeciesHumanMouse
Entrez

808

n/a

Ensembl

ENSG00000160014

n/a

UniProt

P0DP23
Q96HY3
P0DP24

n/a

RefSeq (mRNA)
NM_001329921
NM_001329922
NM_001329923
NM_001329924
NM_001329925

NM_001329926
NM_005184

n/a

RefSeq (protein)
NP_001292553
NP_001292554
NP_001292555
NP_001734
NP_001316850

NP_001316851
NP_001316852
NP_001316853
NP_001316854
NP_001316855
NP_005175
NP_008819
NP_001292554.1
NP_001292555.1
NP_001350598
NP_001350599
NP_008819
NP_001292553
NP_001292554
NP_001292555
NP_001734
NP_001316850
NP_001316851
NP_001316852
NP_001316853
NP_001316854
NP_001316855
NP_005175

n/a

Location (UCSC)Chr 19: 46.6 – 46.61 Mbn/a
PubMed search[2]n/a
Wikidata
View/Edit Human

Calmodulin 3 is a protein that in humans is encoded by the CALM3 gene.

CALM-3 is best known for contracting the heart muscles, and depending on whether this activity is consistent or not, other diseases could emerge as a downside. It is able to maintain or regulate in different types of biological systems, such as cytokinesis or the centrosome cycle.[3]

Calmodulin-3 is able to perform different types of activities and roles, such as binding of calcium and significant activity in regulating an enzyme.[4] The gene CALM-3 is likely to contribute to illnesses that may lead to death, such as Ventricular tachycardia which is associated with the ventricular tachycardia functioning in 2 directions and long QT syndrome which is associated with the QT interval in the electrocardiogram that is significantly longer than normal.[4] In its structure, there are 2 helices that are observed in each of its helix-loop-helix and are then shaped into a perpendicular pattern due to the surface of the protein changing over time.[5] Through transcription, the gene CALM-3 is able to perform the activity of a regulator for its own gene expression and has 6 exons, indicating that each exon has a specific function that takes place in the initiation stage.[6] If there are potentially variants that could impact the calmodulin protein, it could affect the concentration of the Ca mediators that are a part of the protein.[7]

Context

The CALM-3 gene, along with the protein of calmodulin, has been included in different types of experiments such as DNA isolation that is most common in laboratory animals such as rats. This gene can be detected in animals and humans, mainly through our genomes, and its specific polymorphisms can be found through different types of restriction enzymes.[8] In hospital settings, a process named whole exome sequencing are used and are beneficial in determining whether CALM-3 is a cause of a certain disease.[9] Because the protein calmodulin consists of 3 different genes, it may be difficult to determine exactly how the gene can cause a certain disease to occur and potentially worsen.[9] However, there have been few mutations that were detected in the genes of the calmodulin protein such as in long QT syndrome.[9]

Clinical significance

There is significant evidence that Calmodulin-3 may be associated with certain diseases, however there are few evidence that this particular gene contributes to diseases that can cause a sudden death as a result. In the lab experiment with rats, lambda rCB1 or hCE1 underwent DNA isolation as both of the genes included the CALM-3 gene, and was compared with 2 different genes that are more common among rats such as genes lambda SC4 and lambda SC8.[8] As a result, although the lambda rCB1 or hCE1 gene may have different structures from the other genes that rats contain in their genomes, its coding strands were fairly similar.[8] As the process of whole exome sequencing was used for patients with long QT syndrome, there was a certain criteria that had to be met in order to fully go through WES such as the patient having a stable or normal medical family history.[9] Based on an electrocardiogram, the rhythms and waves can be detected and if irregular, it could lead to the pathway of long QT syndrome.[9]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000160014 – Ensembl, May 2017
  2. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  3. ^ "CALM3 - Calmodulin-3 - Homo sapiens (Human) - CALM3 gene & protein". www.uniprot.org. Retrieved 2022-05-18.
  4. ^ a b "CALM3 - Calmodulin-3 - Homo sapiens (Human) - CALM3 gene & protein". www.uniprot.org. Retrieved 2022-04-16.
  5. ^ Zhang M, Yuan T (2011-01-24). "Molecular mechanisms of calmodulin's functional versatility". Biochemistry and Cell Biology. 76 (2–3): 313–323. doi:10.1139/o98-027. PMID 9923700.
  6. ^ Koller M, Schnyder B, Strehler EE (October 1990). "Structural organization of the human CaMIII calmodulin gene". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1087 (2): 180–189. doi:10.1016/0167-4781(90)90203-E. PMID 2223880.
  7. ^ Friedrich FW, Bausero P, Sun Y, Treszl A, Krämer E, Juhr D, et al. (July 2009). "A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy". European Heart Journal. 30 (13): 1648–1655. doi:10.1093/eurheartj/ehp153. PMID 19429631.
  8. ^ a b c SenGupta B, Friedberg F, Detera-Wadleigh SD (December 1987). "Molecular analysis of human and rat calmodulin complementary DNA clones. Evidence for additional active genes in these species". The Journal of Biological Chemistry. 262 (34): 16663–16670. doi:10.1016/S0021-9258(18)49306-4. PMID 2445749.
  9. ^ a b c d e Reed GJ, Boczek NJ, Etheridge SP, Ackerman MJ (February 2015). "CALM3 mutation associated with long QT syndrome". Heart Rhythm. 12 (2): 419–422. doi:10.1016/j.hrthm.2014.10.035. PMC 4907373. PMID 25460178.

Further reading

  • Zhang M, Yuan T (1999). "Molecular mechanisms of calmodulin's functional versatility". Biochemistry and Cell Biology. 76 (2–3): 313–323. doi:10.1139/bcb-76-2-3-313. PMID 9923700.
  • Gusev NB (October 2001). "Some properties of caldesmon and calponin and the participation of these proteins in regulation of smooth muscle contraction and cytoskeleton formation". Biochemistry. Biokhimiia. 66 (10): 1112–1121. doi:10.1023/A:1012480829618. PMID 11736632. S2CID 310781.
  • Benaim G, Villalobo A (August 2002). "Phosphorylation of calmodulin. Functional implications". European Journal of Biochemistry. 269 (15): 3619–3631. doi:10.1046/j.1432-1033.2002.03038.x. hdl:10261/79981. PMID 12153558.
  • Chattopadhyaya R, Meador WE, Means AR, Quiocho FA (December 1992). "Calmodulin structure refined at 1.7 A resolution". Journal of Molecular Biology. 228 (4): 1177–1192. doi:10.1016/0022-2836(92)90324-D. PMID 1474585.
  • Koller M, Schnyder B, Strehler EE (October 1990). "Structural organization of the human CaMIII calmodulin gene". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1087 (2): 180–189. doi:10.1016/0167-4781(90)90203-e. PMID 2223880.
  • Pegues JC, Friedberg F (November 1990). "Multiple mRNAs encoding human calmodulin". Biochemical and Biophysical Research Communications. 172 (3): 1145–1149. doi:10.1016/0006-291X(90)91567-C. PMID 2244899.
  • Baudier J, Mochly-Rosen D, Newton A, Lee SH, Koshland DE, Cole RD (May 1987). "Comparison of S100b protein with calmodulin: interactions with melittin and microtubule-associated tau proteins and inhibition of phosphorylation of tau proteins by protein kinase C". Biochemistry. 26 (10): 2886–2893. doi:10.1021/bi00384a033. PMID 3111527.
  • Fischer R, Koller M, Flura M, Mathews S, Strehler-Page MA, Krebs J, et al. (November 1988). "Multiple divergent mRNAs code for a single human calmodulin". The Journal of Biological Chemistry. 263 (32): 17055–17062. doi:10.1016/S0021-9258(18)37497-0. PMID 3182832.
  • Wawrzynczak EJ, Perham RN (August 1984). "Isolation and nucleotide sequence of a cDNA encoding human calmodulin". Biochemistry International. 9 (2): 177–185. PMID 6385987.
  • Sasagawa T, Ericsson LH, Walsh KA, Schreiber WE, Fischer EH, Titani K (May 1982). "Complete amino acid sequence of human brain calmodulin". Biochemistry. 21 (10): 2565–2569. doi:10.1021/bi00539a041. PMID 7093203.
  • Cook WJ, Walter LJ, Walter MR (December 1994). "Drug binding by calmodulin: crystal structure of a calmodulin-trifluoperazine complex". Biochemistry. 33 (51): 15259–15265. doi:10.1021/bi00255a006. PMID 7803388.
  • Rhyner JA, Ottiger M, Wicki R, Greenwood TM, Strehler EE (October 1994). "Structure of the human CALM1 calmodulin gene and identification of two CALM1-related pseudogenes CALM1P1 and CALM1P2". European Journal of Biochemistry. 225 (1): 71–82. doi:10.1111/j.1432-1033.1994.00071.x. PMID 7925473.
  • Srinivas SK, Srinivas RV, Anantharamaiah GM, Compans RW, Segrest JP (October 1993). "Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins". The Journal of Biological Chemistry. 268 (30): 22895–22899. doi:10.1016/S0021-9258(18)41610-9. PMID 8226798.
  • Miller MA, Mietzner TA, Cloyd MW, Robey WG, Montelaro RC (November 1993). "Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein". AIDS Research and Human Retroviruses. 9 (11): 1057–1066. doi:10.1089/aid.1993.9.1057. PMID 8312049.
  • Berchtold MW, Egli R, Rhyner JA, Hameister H, Strehler EE (May 1993). "Localization of the human bona fide calmodulin genes CALM1, CALM2, and CALM3 to chromosomes 14q24-q31, 2p21.1-p21.3, and 19q13.2-q13.3". Genomics. 16 (2): 461–465. doi:10.1006/geno.1993.1211. PMID 8314583.
  • Koller M, Strehler EE (April 1993). "Functional analysis of the promoters of the human CaMIII calmodulin gene and of the intronless gene coding for a calmodulin-like protein". Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1163 (1): 1–9. doi:10.1016/0167-4838(93)90271-R. PMID 8476923.
  • Radding W, Pan ZQ, Hunter E, Johnston P, Williams JP, McDonald JM (January 1996). "Expression of HIV-1 envelope glycoprotein alters cellular calmodulin". Biochemical and Biophysical Research Communications. 218 (1): 192–197. doi:10.1006/bbrc.1996.0034. PMID 8573130.
  • Pan Z, Radding W, Zhou T, Hunter E, Mountz J, McDonald JM (September 1996). "Role of calmodulin in HIV-potentiated Fas-mediated apoptosis". The American Journal of Pathology. 149 (3): 903–910. PMC 1865159. PMID 8780394.
  • Sasaki M, Uchiyama J, Ishikawa H, Matsushita S, Kimura G, Nomoto K, Koga Y (October 1996). "Induction of apoptosis by calmodulin-dependent intracellular Ca2+ elevation in CD4+ cells expressing gp 160 of HIV". Virology. 224 (1): 18–24. doi:10.1006/viro.1996.0502. PMID 8862395.

External links

  • Human CALM3 genome location and CALM3 gene details page in the UCSC Genome Browser.
  • Overview of all the structural information available in the PDB for UniProt: P0DP23 (Calmodulin-1) at the PDBe-KB.
  • Overview of all the structural information available in the PDB for UniProt: P0DP24 (Calmodulin-2) at the PDBe-KB.
  • v
  • t
  • e
  • 1a29: CALMODULIN COMPLEXED WITH TRIFLUOPERAZINE (1:2 COMPLEX)
    1a29: CALMODULIN COMPLEXED WITH TRIFLUOPERAZINE (1:2 COMPLEX)
  • 1ahr: CALMODULIN MUTANT WITH A TWO RESIDUE DELETION IN THE CENTRAL HELIX
    1ahr: CALMODULIN MUTANT WITH A TWO RESIDUE DELETION IN THE CENTRAL HELIX
  • 1ak8: NMR SOLUTION STRUCTURE OF CERIUM-LOADED CALMODULIN AMINO-TERMINAL DOMAIN (CE2-TR1C), 23 STRUCTURES
    1ak8: NMR SOLUTION STRUCTURE OF CERIUM-LOADED CALMODULIN AMINO-TERMINAL DOMAIN (CE2-TR1C), 23 STRUCTURES
  • 1cdl: TARGET ENZYME RECOGNITION BY CALMODULIN: 2.4 ANGSTROMS STRUCTURE OF A CALMODULIN-PEPTIDE COMPLEX
    1cdl: TARGET ENZYME RECOGNITION BY CALMODULIN: 2.4 ANGSTROMS STRUCTURE OF A CALMODULIN-PEPTIDE COMPLEX
  • 1cdm: MODULATION OF CALMODULIN PLASTICITY IN MOLECULAR RECOGNITION ON THE BASIS OF X-RAY STRUCTURES
    1cdm: MODULATION OF CALMODULIN PLASTICITY IN MOLECULAR RECOGNITION ON THE BASIS OF X-RAY STRUCTURES
  • 1cfc: CALCIUM-FREE CALMODULIN
    1cfc: CALCIUM-FREE CALMODULIN
  • 1cfd: CALCIUM-FREE CALMODULIN
    1cfd: CALCIUM-FREE CALMODULIN
  • 1cff: NMR SOLUTION STRUCTURE OF A COMPLEX OF CALMODULIN WITH A BINDING PEPTIDE OF THE CA2+-PUMP
    1cff: NMR SOLUTION STRUCTURE OF A COMPLEX OF CALMODULIN WITH A BINDING PEPTIDE OF THE CA2+-PUMP
  • 1ckk: CALMODULIN/RAT CA2+/CALMODULIN DEPENDENT PROTEIN KINASE FRAGMENT
    1ckk: CALMODULIN/RAT CA2+/CALMODULIN DEPENDENT PROTEIN KINASE FRAGMENT
  • 1cll: CALMODULIN STRUCTURE REFINED AT 1.7 ANGSTROMS RESOLUTION
    1cll: CALMODULIN STRUCTURE REFINED AT 1.7 ANGSTROMS RESOLUTION
  • 1cm1: MOTIONS OF CALMODULIN-SINGLE-CONFORMER REFINEMENT
    1cm1: MOTIONS OF CALMODULIN-SINGLE-CONFORMER REFINEMENT
  • 1cm4: MOTIONS OF CALMODULIN-FOUR-CONFORMER REFINEMENT
    1cm4: MOTIONS OF CALMODULIN-FOUR-CONFORMER REFINEMENT
  • 1cmf: NMR SOLUTION STRUCTURE OF APO CALMODULIN CARBOXY-TERMINAL DOMAIN
    1cmf: NMR SOLUTION STRUCTURE OF APO CALMODULIN CARBOXY-TERMINAL DOMAIN
  • 1cmg: NMR SOLUTION STRUCTURE OF CALCIUM-LOADED CALMODULIN CARBOXY-TERMINAL DOMAIN
    1cmg: NMR SOLUTION STRUCTURE OF CALCIUM-LOADED CALMODULIN CARBOXY-TERMINAL DOMAIN
  • 1ctr: DRUG BINDING BY CALMODULIN: CRYSTAL STRUCTURE OF A CALMODULIN-TRIFLUOPERAZINE COMPLEX
    1ctr: DRUG BINDING BY CALMODULIN: CRYSTAL STRUCTURE OF A CALMODULIN-TRIFLUOPERAZINE COMPLEX
  • 1deg: THE LINKER OF DES-GLU84 CALMODULIN IS BENT AS SEEN IN THE CRYSTAL STRUCTURE
    1deg: THE LINKER OF DES-GLU84 CALMODULIN IS BENT AS SEEN IN THE CRYSTAL STRUCTURE
  • 1dmo: CALMODULIN, NMR, 30 STRUCTURES
    1dmo: CALMODULIN, NMR, 30 STRUCTURES
  • 1f70: REFINED SOLUTION STRUCTURE OF CALMODULIN N-TERMINAL DOMAIN
    1f70: REFINED SOLUTION STRUCTURE OF CALMODULIN N-TERMINAL DOMAIN
  • 1f71: REFINED SOLUTION STRUCTURE OF CALMODULIN C-TERMINAL DOMAIN
    1f71: REFINED SOLUTION STRUCTURE OF CALMODULIN C-TERMINAL DOMAIN
  • 1fw4: CRYSTAL STRUCTURE OF E. COLI FRAGMENT TR2C FROM CALMODULIN TO 1.7 A RESOLUTION
    1fw4: CRYSTAL STRUCTURE OF E. COLI FRAGMENT TR2C FROM CALMODULIN TO 1.7 A RESOLUTION
  • 1g4y: 1.60 A CRYSTAL STRUCTURE OF THE GATING DOMAIN FROM SMALL CONDUCTANCE POTASSIUM CHANNEL COMPLEXED WITH CALCIUM-CALMODULIN
    1g4y: 1.60 A CRYSTAL STRUCTURE OF THE GATING DOMAIN FROM SMALL CONDUCTANCE POTASSIUM CHANNEL COMPLEXED WITH CALCIUM-CALMODULIN
  • 1iq5: Calmodulin/nematode CA2+/Calmodulin dependent kinase kinase fragment
    1iq5: Calmodulin/nematode CA2+/Calmodulin dependent kinase kinase fragment
  • 1iwq: Crystal Structure of MARCKS calmodulin binding domain peptide complexed with Ca2+/Calmodulin
    1iwq: Crystal Structure of MARCKS calmodulin binding domain peptide complexed with Ca2+/Calmodulin
  • 1j7o: Solution structure of Calcium-calmodulin N-terminal domain
    1j7o: Solution structure of Calcium-calmodulin N-terminal domain
  • 1j7p: Solution structure of Calcium calmodulin C-terminal domain
    1j7p: Solution structure of Calcium calmodulin C-terminal domain
  • 1k90: Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin and 3' deoxy-ATP
    1k90: Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin and 3' deoxy-ATP
  • 1k93: Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin
    1k93: Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin
  • 1l7z: Crystal structure of Ca2+/Calmodulin complexed with myristoylated CAP-23/NAP-22 peptide
    1l7z: Crystal structure of Ca2+/Calmodulin complexed with myristoylated CAP-23/NAP-22 peptide
  • 1lin: CALMODULIN COMPLEXED WITH TRIFLUOPERAZINE (1:4 COMPLEX)
    1lin: CALMODULIN COMPLEXED WITH TRIFLUOPERAZINE (1:4 COMPLEX)
  • 1lvc: Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin and 2' deoxy, 3' anthraniloyl ATP
    1lvc: Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin and 2' deoxy, 3' anthraniloyl ATP
  • 1mux: SOLUTION NMR STRUCTURE OF CALMODULIN/W-7 COMPLEX: THE BASIS OF DIVERSITY IN MOLECULAR RECOGNITION, 30 STRUCTURES
    1mux: SOLUTION NMR STRUCTURE OF CALMODULIN/W-7 COMPLEX: THE BASIS OF DIVERSITY IN MOLECULAR RECOGNITION, 30 STRUCTURES
  • 1mxe: Structure of the Complex of Calmodulin with the Target Sequence of CaMKI
    1mxe: Structure of the Complex of Calmodulin with the Target Sequence of CaMKI
  • 1niw: Crystal structure of endothelial nitric oxide synthase peptide bound to calmodulin
    1niw: Crystal structure of endothelial nitric oxide synthase peptide bound to calmodulin
  • 1nwd: Solution Structure of Ca2+/Calmodulin bound to the C-terminal Domain of Petunia Glutamate Decarboxylase
    1nwd: Solution Structure of Ca2+/Calmodulin bound to the C-terminal Domain of Petunia Glutamate Decarboxylase
  • 1ooj: Structural genomics of Caenorhabditis elegans : Calmodulin
    1ooj: Structural genomics of Caenorhabditis elegans : Calmodulin
  • 1pk0: Crystal Structure of the EF3-CaM complexed with PMEApp
    1pk0: Crystal Structure of the EF3-CaM complexed with PMEApp
  • 1prw: Crystal structure of bovine brain Ca++ calmodulin in a compact form
    1prw: Crystal structure of bovine brain Ca++ calmodulin in a compact form
  • 1qiv: CALMODULIN COMPLEXED WITH N-(3,3,-DIPHENYLPROPYL)-N'-[1-R-(3,4-BIS-BUTOXYPHENYL)-ETHYL]-PROPYLENEDIAMINE (DPD), 1:2 COMPLEX
    1qiv: CALMODULIN COMPLEXED WITH N-(3,3,-DIPHENYLPROPYL)-N'-[1-R-(3,4-BIS-BUTOXYPHENYL)-ETHYL]-PROPYLENEDIAMINE (DPD), 1:2 COMPLEX
  • 1qiw: CALMODULIN COMPLEXED WITH N-(3,3,-DIPHENYLPROPYL)-N'-[1-R-(3,4-BIS-BUTOXYPHENYL)-ETHYL]-PROPYLENEDIAMINE (DPD)
    1qiw: CALMODULIN COMPLEXED WITH N-(3,3,-DIPHENYLPROPYL)-N'-[1-R-(3,4-BIS-BUTOXYPHENYL)-ETHYL]-PROPYLENEDIAMINE (DPD)
  • 1qs7: The 1.8 angstrom structure of calmodulin rs20 peptide complex
    1qs7: The 1.8 angstrom structure of calmodulin rs20 peptide complex
  • 1qtx: THE 1.65 ANGSTROM STRUCTURE OF CALMODULIN RS20 PEPTIDE COMPLEX
    1qtx: THE 1.65 ANGSTROM STRUCTURE OF CALMODULIN RS20 PEPTIDE COMPLEX
  • 1qx5: Crystal structure of apoCalmodulin
    1qx5: Crystal structure of apoCalmodulin
  • 1qx7: Crystal structure of apoCaM bound to the gating domain of small conductance Ca2+-activated potassium channel
    1qx7: Crystal structure of apoCaM bound to the gating domain of small conductance Ca2+-activated potassium channel
  • 1s26: Structure of Anthrax Edema Factor-Calmodulin-alpha,beta-methyleneadenosine 5'-triphosphate Complex Reveals an Alternative Mode of ATP Binding to the Catalytic Site
    1s26: Structure of Anthrax Edema Factor-Calmodulin-alpha,beta-methyleneadenosine 5'-triphosphate Complex Reveals an Alternative Mode of ATP Binding to the Catalytic Site
  • 1sk6: Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin, 3',5' cyclic AMP (cAMP), and pyrophosphate
    1sk6: Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin, 3',5' cyclic AMP (cAMP), and pyrophosphate
  • 1sw8: Solution structure of the N-terminal domain of Human N60D calmodulin refined with paramagnetism based strategy
    1sw8: Solution structure of the N-terminal domain of Human N60D calmodulin refined with paramagnetism based strategy
  • 1sy9: Structure of calmodulin complexed with a fragment of the olfactory CNG channel
    1sy9: Structure of calmodulin complexed with a fragment of the olfactory CNG channel
  • 1up5: CHICKEN CALMODULIN
    1up5: CHICKEN CALMODULIN
  • 1vrk: THE 1.9 ANGSTROM STRUCTURE OF E84K-CALMODULIN RS20 PEPTIDE COMPLEX
    1vrk: THE 1.9 ANGSTROM STRUCTURE OF E84K-CALMODULIN RS20 PEPTIDE COMPLEX
  • 1wrz: Calmodulin complexed with a peptide from a human death-associated protein kinase
    1wrz: Calmodulin complexed with a peptide from a human death-associated protein kinase
  • 1x02: Solution structure of stereo array isotope labeled (SAIL) calmodulin
    1x02: Solution structure of stereo array isotope labeled (SAIL) calmodulin
  • 1xa5: Structure of Calmodulin in complex with KAR-2, a bis-indol alkaloid
    1xa5: Structure of Calmodulin in complex with KAR-2, a bis-indol alkaloid
  • 1xfu: Crystal structure of anthrax edema factor (EF) truncation mutant, EF-delta 64 in complex with calmodulin
    1xfu: Crystal structure of anthrax edema factor (EF) truncation mutant, EF-delta 64 in complex with calmodulin
  • 1xfv: Crystal structure of anthrax edema factor (EF) in complex with calmodulin and 3' deoxy-ATP
    1xfv: Crystal structure of anthrax edema factor (EF) in complex with calmodulin and 3' deoxy-ATP
  • 1xfw: Crystal structure of anthrax edema factor (EF) in complex with calmodulin and 3'5' cyclic AMP (cAMP)
    1xfw: Crystal structure of anthrax edema factor (EF) in complex with calmodulin and 3'5' cyclic AMP (cAMP)
  • 1xfx: Crystal structure of anthrax edema factor (EF) in complex with calmodulin in the presence of 10 millimolar exogenously added calcium chloride
    1xfx: Crystal structure of anthrax edema factor (EF) in complex with calmodulin in the presence of 10 millimolar exogenously added calcium chloride
  • 1xfy: Crystal structure of anthrax edema factor (EF) in complex with calmodulin
    1xfy: Crystal structure of anthrax edema factor (EF) in complex with calmodulin
  • 1xfz: Crystal structure of anthrax edema factor (EF) in complex with calmodulin in the presence of 1 millimolar exogenously added calcium chloride
    1xfz: Crystal structure of anthrax edema factor (EF) in complex with calmodulin in the presence of 1 millimolar exogenously added calcium chloride
  • 1y0v: Crystal structure of anthrax edema factor (EF) in complex with calmodulin and pyrophosphate
    1y0v: Crystal structure of anthrax edema factor (EF) in complex with calmodulin and pyrophosphate
  • 1y6w: Trapped intermediate of calmodulin
    1y6w: Trapped intermediate of calmodulin
  • 1yr5: 1.7-A structure of calmodulin bound to a peptide from DAP kinase
    1yr5: 1.7-A structure of calmodulin bound to a peptide from DAP kinase
  • 1yrt: Crystal Structure analysis of the adenylyl cyclaes catalytic domain of adenylyl cyclase toxin of Bordetella pertussis in presence of c-terminal calmodulin
    1yrt: Crystal Structure analysis of the adenylyl cyclaes catalytic domain of adenylyl cyclase toxin of Bordetella pertussis in presence of c-terminal calmodulin
  • 1yru: Crystal Structure analysis of the adenylyl cyclaes catalytic domain of adenylyl cyclase toxin of Bordetella pertussis in presence of c-terminal calmodulin and 1mM calcium chloride
    1yru: Crystal Structure analysis of the adenylyl cyclaes catalytic domain of adenylyl cyclase toxin of Bordetella pertussis in presence of c-terminal calmodulin and 1mM calcium chloride
  • 1zot: crystal structure analysis of the CyaA/C-Cam with PMEAPP
    1zot: crystal structure analysis of the CyaA/C-Cam with PMEAPP
  • 1zuz: Calmodulin in complex with a mutant peptide from human DRP-1 kinase
    1zuz: Calmodulin in complex with a mutant peptide from human DRP-1 kinase
  • 2bbm: SOLUTION STRUCTURE OF A CALMODULIN-TARGET PEPTIDE COMPLEX BY MULTIDIMENSIONAL NMR
    2bbm: SOLUTION STRUCTURE OF A CALMODULIN-TARGET PEPTIDE COMPLEX BY MULTIDIMENSIONAL NMR
  • 2bbn: SOLUTION STRUCTURE OF A CALMODULIN-TARGET PEPTIDE COMPLEX BY MULTIDIMENSIONAL NMR
    2bbn: SOLUTION STRUCTURE OF A CALMODULIN-TARGET PEPTIDE COMPLEX BY MULTIDIMENSIONAL NMR
  • 2bcx: Crystal structure of calmodulin in complex with a ryanodine receptor peptide
    2bcx: Crystal structure of calmodulin in complex with a ryanodine receptor peptide
  • 2be6: 2.0 A crystal structure of the CaV1.2 IQ domain-Ca/CaM complex
    2be6: 2.0 A crystal structure of the CaV1.2 IQ domain-Ca/CaM complex
  • 2bkh: MYOSIN VI NUCLEOTIDE-FREE (MDINSERT2) CRYSTAL STRUCTURE
    2bkh: MYOSIN VI NUCLEOTIDE-FREE (MDINSERT2) CRYSTAL STRUCTURE
  • 2bki: MYOSIN VI NUCLEOTIDE-FREE (MDINSERT2-IQ) CRYSTAL STRUCTURE
    2bki: MYOSIN VI NUCLEOTIDE-FREE (MDINSERT2-IQ) CRYSTAL STRUCTURE
  • 2col: Crystal structure analysis of CyaA/C-Cam with Pyrophosphate
    2col: Crystal structure analysis of CyaA/C-Cam with Pyrophosphate
  • 2dfs: 3-D structure of Myosin-V inhibited state
    2dfs: 3-D structure of Myosin-V inhibited state
  • 2f2o: Structure of calmodulin bound to a calcineurin peptide: a new way of making an old binding mode
    2f2o: Structure of calmodulin bound to a calcineurin peptide: a new way of making an old binding mode
  • 2f2p: Structure of calmodulin bound to a calcineurin peptide: a new way of making an old binding mode
    2f2p: Structure of calmodulin bound to a calcineurin peptide: a new way of making an old binding mode
  • 2f3y: Calmodulin/IQ domain complex
    2f3y: Calmodulin/IQ domain complex
  • 2f3z: Calmodulin/IQ-AA domain complex
    2f3z: Calmodulin/IQ-AA domain complex
  • 2fot: Crystal structure of the complex between calmodulin and alphaII-spectrin
    2fot: Crystal structure of the complex between calmodulin and alphaII-spectrin
  • 2hf5: The structure and function of a novel two-site calcium-binding fragment of calmodulin
    2hf5: The structure and function of a novel two-site calcium-binding fragment of calmodulin
  • 2ix7: STRUCTURE OF APO-CALMODULIN BOUND TO UNCONVENTIONAL MYOSIN V
    2ix7: STRUCTURE OF APO-CALMODULIN BOUND TO UNCONVENTIONAL MYOSIN V
  • 3cln: STRUCTURE OF CALMODULIN REFINED AT 2.2 ANGSTROMS RESOLUTION
    3cln: STRUCTURE OF CALMODULIN REFINED AT 2.2 ANGSTROMS RESOLUTION
  • 4cln: STRUCTURE OF A RECOMBINANT CALMODULIN FROM DROSOPHILA MELANOGASTER REFINED AT 2.2-ANGSTROMS RESOLUTION
    4cln: STRUCTURE OF A RECOMBINANT CALMODULIN FROM DROSOPHILA MELANOGASTER REFINED AT 2.2-ANGSTROMS RESOLUTION